SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001171843-19-001649
Filing Date
2019-03-12
Accepted
2019-03-12 16:03:15
Documents
1
Period of Report
2018-10-02

Document Format Files

Seq Description Document Type Size
1 ownership.html 4/A  
1 ownership.xml 4/A 3630
  Complete submission text file 0001171843-19-001649.txt   5024
Mailing Address 100 PHOENIX DRIVE SUITE 190 ANN ARBOR MI 48108
Business Address 100 PHOENIX DRIVE SUITE 190 ANN ARBOR MI 48108 (734) 369-2555
Zomedica Pharmaceuticals Corp. (Issuer) CIK: 0001684144 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O ZOMEDICA PHARMACEUTICALS CORP. 100 PHOENIX DRIVE, SUITE 190 ANN ARBOR MI 48108
Business Address
Solensky Gerald JR (Reporting) CIK: 0001721759 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-38298 | Film No.: 19675100